All Videos

At South Beach Symposium 2026, Mona Shahriari explores OX40/OX40L therapies for atopic dermatitis.

Glynis Ablon, MD, FAAD, examines the intersection of menopause, hormones, and dermatologic health.

At MOPD 2026, Lisa Swanson, MD, urges fungal cultures amid terbinafine resistance and warns attendees about risky kids’ skin care trends.

At South Beach Symposium 2026, Benjamin Ungar, MD, discussed safer, long-term approaches for seborrheic dermatitis.

Glynis Ablon, MD, FAAD, shares insights on diagnosing alopecia fast, managing aesthetic complications, and choosing evidence-based supplements.

David Cotter, MD, PhD, underscored the importance of incorporating quality-of-life and mental health measures into psoriasis clinical trials.

At MOPD 2026, Kristina Derrick, MD, ScM, links teen acne to hormones and metabolism, highlighting PCOS clues and antiandrogen therapies.

Parents of children with chronic skin conditions seek guidance on managing flares and long-term treatment strategies for better outcomes.

Experts discuss effective eczema management for young children, emphasizing treatment options, parental education, and the importance of long-term care strategies.

James Del Rosso, DO, discusses diagnosis and treatment of mastocytosis and inflammatory conditions.

Discover effective strategies for addressing patients' "I'm fine" responses and uncovering hidden health concerns through guided questions and assessments.

Explore the evolving concept of on-treatment remission in psoriasis management and its impact on patient care and quality of life.

Jennelle Daly, PA-C, explores the integration of aesthetic dermatology and wellness, emphasizing holistic approaches for optimal skin health and patient outcomes.

Galderma's Bill Andriopoulos, PhD, discusses Dysport's real-world success and evolving trends in aesthetic injectables, emphasizing patient satisfaction and innovative treatments.

James Del Rosso, DO, discusses innovative therapies for chronic hand eczema (CHE), chronic spontaneous urticaria (CSU), and vitiligo.

Discover insights from Bill Andriopoulos, PhD, on Relfydess, a groundbreaking neuromodulator utilizing PEARL Technology for enhanced efficacy and safety.

Explore the importance of high-energy visible (HEV) blue light protection, especially post procedures, and discover effective patient strategies for managing melasma and skin health.

A pediatric case highlights the challenges of managing severe atopic dermatitis in infants, emphasizing the need for effective treatment strategies.

An 18-month-old with severe atopic dermatitis experiences rapid flare-ups, prompting a discussion on treatment options and potential triggers.

Jennelle Daly, MPAS, PA-C, reveals essential winter sunscreen insights, emphasizing UVA risks and patient education for effective photoprotection against melanoma.

Clinicians discuss evolving psoriasis treatment goals, emphasizing clear benchmarks for patient understanding and improved outcomes in therapy.

Experts discuss how psoriasis treatment targets have dramatically evolved. Historically, a 50-75% skin improvement (PASI 50/75) was the benchmark for success. With modern systemic therapies, including advanced biologics targeting IL-17, IL-23, and oral agents, the goal is now near or complete 100% skin clearance. The panel emphasizes that early and aggressive intervention with systemic treatment is key to changing the disease course and achieving sustained remission. This "treat-to-target" mindset aligns with higher patient expectations and recognizes psoriasis as a systemic condition requiring internal therapy. Clearing the skin externally signifies reduced internal inflammation, fundamentally redefining psoriasis treatment success towards achieving clear skin and improved long-term patient quality of life.

Explore the transformative role of AI in dermatology with Nawar Shara, PhD, focusing on personalized skin care and patient safety.

James Del Rosso, DO, discusses innovative topical therapies for dermatologic conditions.

Explore effective management strategies for atopic dermatitis in children, focusing on non-steroidal options and addressing parental concerns.

Healthcare professionals discuss effective educational strategies for managing chronic skin conditions, emphasizing proactive treatment and patient understanding.

BioMendics is advancing TolaSure in the TAMES-02 trial for EBS, aiming for rapid market access and potential expansion to other keratinopathies.

Michael O'Donoghue, MD, discusses tailoring PDT for AK, emphasizing patient preferences and flexible treatment strategies.

Karen McGuire, PhD, discusses innovative TolaSure for treating epidermolysis bullosa simplex, focusing on disease modification rather than symptom management.

Renata Block, DMSc, MMS, PA-C, explores how AI could transform dermatology with insights from Dr. GPT on integration, equity, and the future of patient care.